Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pfizer Ltd. Capital/Financing Update 2024

Dec 30, 2024

60507_rns_2024-12-30_36eec34c-ff53-4af6-85f5-e7d61181eaa3.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [101 x 42] intentionally omitted <==

Pfizer Limited

The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

December 30, 2024

The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1[st] Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Plot No. C/1, Dalal Street, Fort G Block Bandra-Kurla Complex, Bandra (E) Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 500680 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Closure of Trading Window

We would like to inform you that, for the purpose of declaration of unaudited financial results of the Company for the quarter and nine months ending December 31, 2024, the trading window of the Company shall remain closed from Tuesday, December 31, 2024 (close of business hours) till 48 hours after the financial results are made public.

We request you to kindly take the same on record.

Thanking you,

Yours truly, For Pfizer Limited PRAJEET Digitally signed by PRAJEET NAIR NAIR Date: 2024.12.30 20:11:38 +05'30' Prajeet Nair

Director – Corporate Services & Company Secretary

Cc.: National Securities Depository Limited (NSDL)

Central Depository Services (India) Limited (CDSL) KFin Technologies Limited

CIN: L24231MH1950PLC008311 Email ID: [email protected] Website: www.pfizerltd.co.in